On August 25, Great Wall Motor released its 2026 semi-annual report. According to the data, the company achieved both revenue and sales growth in the first half of the year, and the operation was steady and improving. In terms of revenue and profit, in the first half of 2026, the company achieved operating income of 102.01 billion yuan, an increase of 10.58%; gross profit for the period was 18.759 billion yuan, up 10.52% year on year, and profit quality improved steadily. At the same time, the company's net cash flow from operating activities reached 10.436 billion yuan, an increase of 13.25% over the previous year, and endogenous hematopoietic capacity continued to strengthen. On the sales side, the company's cumulative sales volume of new vehicles in the first half of the year was 575,800 units, an increase of 1.22% over the previous year. Overseas markets performed well, with sales of 289,000 new vehicles overseas, up 45.46% year on year, becoming an important driving force for the company's overall business growth. Overall, Great Wall Motor focuses on “hematopoietic” capabilities, continues to cultivate high-quality management, and continues to increase overall management resilience. Relying on the accelerated realization of market value on the Guiyuan platform and the popularity of models such as the Great Wall H10, global growth space will be further opened up.

Zhitongcaijing · 2d ago
On August 25, Great Wall Motor released its 2026 semi-annual report. According to the data, the company achieved both revenue and sales growth in the first half of the year, and the operation was steady and improving. In terms of revenue and profit, in the first half of 2026, the company achieved operating income of 102.01 billion yuan, an increase of 10.58%; gross profit for the period was 18.759 billion yuan, up 10.52% year on year, and profit quality improved steadily. At the same time, the company's net cash flow from operating activities reached 10.436 billion yuan, an increase of 13.25% over the previous year, and endogenous hematopoietic capacity continued to strengthen. On the sales side, the company's cumulative sales volume of new vehicles in the first half of the year was 575,800 units, an increase of 1.22% over the previous year. Overseas markets performed well, with sales of 289,000 new vehicles overseas, up 45.46% year on year, becoming an important driving force for the company's overall business growth. Overall, Great Wall Motor focuses on “hematopoietic” capabilities, continues to cultivate high-quality management, and continues to increase overall management resilience. Relying on the accelerated realization of market value on the Guiyuan platform and the popularity of models such as the Great Wall H10, global growth space will be further opened up.